EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION-24-MONTH RESULTS FROM H2305 STUDY.

被引：0
|
作者：
Ganschow, R. [1 ]
Ericzon, B. -G. [2 ]
Dhawan, A. [3 ]
Sharif, K. [4 ]
Martzloff, E. -D. [5 ]
Rauer, B. [5 ]
Ng, J. [6 ]
Lopez, P. M. [5 ]
机构：
[1] Univ Med Ctr, Bonn, Germany
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Kings Coll Hosp London, London, England
[4] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham, W Midlands, England
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, East Hannover, NJ USA
来源：
PEDIATRIC TRANSPLANTATION | 2017年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
213.2
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [2] EFFICACY AND SAFETY OF EVEROLIMUS (EVR) WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS (PLTXR): 24-MONTH RESULTS FROM H2305-STUDY (NCT01598987)
    Ganschow, R.
    Ericzon, B. G.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 37 - 37
  • [3] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 719 - 719
  • [4] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    [J]. TRANSPLANTATION, 2014, 98 : 719 - 719
  • [5] Rationale and Design of a 24-Month, Prospective, International Study Assessing the Efficacy, Safety and Tolerability of Everolimus with Reduced Exposure to Cyclosporine or Tacrolimus in Pediatric Liver Transplant Recipients.
    Ganschow, R.
    Fischer, L.
    Torre, G.
    Langer, R. M.
    Ericzon, B. G.
    Brunati, A.
    Sips, C.
    Balfour, A.
    Junge, G.
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S176 - S176
  • [6] Everolimus in Combination With Reduced Calcineurin Inhibitor in Paediatric Liver Transplant Recipients: Baseline Data from the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B. -G.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S281 - S282
  • [7] LINEAR GROWTH AND SEXUAL MATURATION WITH EVEROLIMUS PLUS REDUCED CALCINEURIN INHIBITOR-BASED REGIMEN IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS: 12-MONTH RESULTS FROM H2305 STUDY.
    Briem-Richter, A.
    Brinkert, F.
    Grabhorn, E.
    Yap, J. K.
    Rasmussen, A.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 13 - 13
  • [8] Everolimus with low-dose calcineurin inhibitor in pediatric liver transplant recipients: 12-month results of the H2305 study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Aguilar, Jose A.
    Ng, Jennifer
    Lopez, Patricia M.
    [J]. HEPATOLOGY, 2016, 64 : 493A - 493A
  • [9] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [10] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    [J]. TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
12345